Enlivex Ltd.
Allocetra
age-related symptomatic primary knee osteoarthritis
Date
TBD
Phase 2 readout · Date TBD estimated
What's at stake
Phase 2 trial results for Allocetra in age-related symptomatic primary knee osteoarthritis are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“The FDA’s clearance enables Enlivex to initiate a global, multicenter, randomized, double-blind, placebo-controlled Phase 2b clinical trial designed to evaluate the efficacy and safety of intra-articular injections of Allocetra™ in patients”